As a complementary approach to previous studies on genetic and epigenetic changes, we have used chemical genetics to identify signaling pathways and epigenetic machinery that directly or indirectly influence DUX4 expression in FSHD muscle. This evidence concerns the gene DUX4 and Facioscapulohumeral dystrophy.